Genomics BioSci & Tech Co (TPE:4195) Cyclically Adjusted Book per Share: NT$12.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4195 Genomics BioSci & Tech Co Ltd TPE:4195
42 GF Score
Price NT$15.35
GF Value NT$34.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Genomics BioSci & Tech Co Cyclically Adjusted Book per Share?

Genomics BioSci & Tech Co TPE:4195 +0.33% 42 Cyclically Adjusted Book per Share is NT$12.25 as of Mar. 2026. GuruFocus rates TPE:4195 with a GF Score™ of 42/100 and a GF Value™ of NT$34.60 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Genomics BioSci & Tech Co's adjusted book value per share data for the fiscal year that ended in Dec. 2025 was NT$7.044. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$12.25 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -2.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Genomics BioSci & Tech Co was 5.30% per year. The lowest was -2.50% per year. And the median was 2.20% per year.

As of today (2026-08-09), Genomics BioSci & Tech Co's current stock price is NT$ 15.35. Genomics BioSci & Tech Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec. 2025 was NT$12.25. Genomics BioSci & Tech Co's Cyclically Adjusted PB Ratio of today is 1.25.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genomics BioSci & Tech Co was 2.13. The lowest was 1.25. And the median was 1.95.


Genomics BioSci & Tech Co  (TPE:4195) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Genomics BioSci & Tech Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.35/12.25
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genomics BioSci & Tech Co was 2.13. The lowest was 1.25. And the median was 1.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Genomics BioSci & Tech Co Cyclically Adjusted Book per Share Related Terms


Genomics BioSci & Tech Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Genomics BioSci & Tech Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomics BioSci & Tech Co Cyclically Adjusted Book per Share Chart

Genomics BioSci & Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.59 13.23 13.32 12.76 12.25

Genomics BioSci & Tech Co Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 12.25 0.00

TPE:4195 vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Genomics BioSci & Tech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomics BioSci & Tech Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genomics BioSci & Tech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genomics BioSci & Tech Co's Cyclically Adjusted PB Ratio falls into.


TPE:4195
42GF Score
Genomics BioSci & Tech Co Ltd TPE:4195
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomics BioSci & Tech Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomics BioSci & Tech Co's adjusted Book Value per Share data for the fiscal year that ended in Dec. 2025 was:

Adj_Book=Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=7.044/324.0540*324.0540
=7.044

Current CPI (Dec. 2025) = 324.0540.

Genomics BioSci & Tech Co Annual Data

Book Value per Share CPI Adj_Book
201612 11.219 241.432 15.058
201712 10.938 246.524 14.378
201812 9.941 251.233 12.822
201912 11.329 256.974 14.286
202012 11.010 260.474 13.697
202112 11.127 278.802 12.933
202212 12.193 296.797 13.313
202312 10.566 306.746 11.162
202412 7.574 315.605 7.777
202512 7.044 324.054 7.044

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$12.25 mean?
Genomics BioSci & Tech Co (TPE:4195) has a Cyclically Adjusted Book per Share of NT$12.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genomics BioSci & Tech Co and its competitors.
Is Genomics BioSci & Tech Co's Cyclically Adjusted Book per Share too high?
Genomics BioSci & Tech Co's current Cyclically Adjusted Book per Share is NT$12.25. Overall, Genomics BioSci & Tech Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genomics BioSci & Tech Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Genomics BioSci & Tech Co's Cyclically Adjusted Book per Share of NT$12.25 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genomics BioSci & Tech Co and its competitors. Genomics BioSci & Tech Co's current Cyclically Adjusted Book per Share is NT$12.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomics BioSci & Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Genomics BioSci & Tech Co (TPE:4195) is currently considered Possible Value Trap. The stock's GF Value™ is NT$34.60, compared to a current price of NT$15.35 — trading 55.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$12.25. Genomics BioSci & Tech Co's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Genomics BioSci & Tech Co (TPE:4195), the current Cyclically Adjusted Book per Share is NT$12.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomics BioSci & Tech Co (TPE:4195) Overvalued in 2026?

Based on GuruFocus' analysis, Genomics BioSci & Tech Co stock appears to be undervalued. The current stock price of NT$15.35 is trading 55.6% below its estimated GF Value™ of NT$34.60. GuruFocus considers Genomics BioSci & Tech Co to be Possible Value Trap.

Key valuation signals for TPE:4195:

  • Cyclically Adjusted Book per Share: NT$12.25
  • GF Value™: NT$34.60 vs. price of NT$15.35 (55.6% below fair value)
  • GF Score™: 42/100 with 6 warning signs

No single metric tells the full story. See the TPE:4195 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genomics BioSci & Tech Co Business Description

Address 14th Floor, Number 100, Xintai 5th Road, Sec 1, Xizhi District, New Taipei City, Taipei, TWN
Genomics BioSci & Tech Co Ltd is a Taiwan based commercial genome sequencing company formed to develop medical genetic testing. The services of the company include Sanger sequence service, Synthesis Service and Genomic Service.
42GF Score

Get the complete analysis for TPE:4195

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.35
Price
NT$34.60
GF Value